J Int Neuropsychol Soc. 1995 May;1(3):304-15.

Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center.

Source

Department of Psychiatry, University of California, San Diego, La Jolla 92093, USA.

Abstract

The current review was conducted to address the ongoing debate regarding the presence or absence of neuropsychological impairment in asymptomatic HIV-Type 1 (HIV-1) seropositive individuals. Results were summarized from 57 studies that compared the performances of seropositive asymptomatic and seronegative individuals. Overall, the differences observed between median rates of impairment for asymptomatic (35%) and seronegative (12%) groups provided the clearest indication of deficits in asymptomatics. In addition, five variables were examined as possible contributors to inconsistencies found in the literature: mode of infection, test battery type, test battery size, sample size, and method of data analysis. Of these variables, only mode of infection and test battery size appeared to substantially influence the outcome of the studies reviewed with regard to identifying neuropsychological impairment in asymptomatics.

PMID:: 9375225; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Grant Support

Publication Types

MeSH Terms

Grant Support

LinkOut - more resources

Full Text Sources

OhioLINK Electronic Journal Center

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users (IVDUs): a follow-up study. [J Int Neuropsychol Soc. 1996]
Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users (IVDUs): a follow-up study.
Hestad K, Aukrust P, Ellertsen B, Kløve H. J Int Neuropsychol Soc. 1996 Mar; 2(2):126-33.
Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. [Psychosom Med. 1994]
Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center.
Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant I. Psychosom Med. 1994 Jan-Feb; 56(1):8-17.
Neuropsychological performance in asymptomatic HIV infection. [J Neuropsychiatry Clin Neurosc...]
Neuropsychological performance in asymptomatic HIV infection.
Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ, Rice R Jr. J Neuropsychiatry Clin Neurosci. 1992 Fall; 4(4):386-94.
Review Neuropsychological effects of early HIV-1 infection: assessment and methodology. [J Neuropsychiatry Clin Neurosc...]
Review Neuropsychological effects of early HIV-1 infection: assessment and methodology.
Ingraham LJ, Bridge TP, Janssen R, Stover E, Mirsky AF. J Neuropsychiatry Clin Neurosci. 1990 Spring; 2(2):174-82.
Review Early neuropsychological dysfunction caused by human immunodeficiency virus. [J Neuropsychiatry Clin Neurosc...]
Review Early neuropsychological dysfunction caused by human immunodeficiency virus.
Marotta R, Perry S. J Neuropsychiatry Clin Neurosci. 1989 Summer; 1(3):225-35.

See reviews... See all...

Cited by 16 PubMed Central articles

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. [J Neurovirol. 2011]
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, et al. J Neurovirol. 2011 Feb; 17(1):3-16. Epub 2010 Dec 21.
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. [Neurology. 2010]
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, et al. Neurology. 2010 Dec 7; 75(23):2087-96.
Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. [AIDS Res Hum Retroviruses. 2009]
Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes.
Gandhi N, Saiyed Z, Thangavel S, Rodriguez J, Rao KV, Nair MP. AIDS Res Hum Retroviruses. 2009 Jul; 25(7):691-9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 i...
Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center.
J Int Neuropsychol Soc. 1995 May ;1(3):304-15.

PubMed
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV ...
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.
J Int Neuropsychol Soc. 1995 May ;1(3):231-51.

PubMed
Medicine based evidence, a prerequisite for evidence based medicine.
Medicine based evidence, a prerequisite for evidence based medicine.
BMJ. 1997 Nov 1 ;315(7116):1109-10.

PubMed
Comparison of two independent crystal structures of human dihydrofolate reductas...
Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.
Biochemistry. 1997 Nov 11 ;36(45):13897-903.

PubMed
Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic...
Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Am J Physiol. 1997 Nov ;273(5 Pt 2):H2534-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: